The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Brovarone Dennis since 2007.
The trader's CIK number is 1053769.
At the time of the last reporting, Brovarone Dennis was the Director of Pure Bioscience, Inc.. (stock ticker symbol PURE).
Also see all insider trading activities at Pure Bioscience, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | PURE | 0 | $0 | 170,000 | $398,013 | 150,000 | $79,500 |
| 2009 | PURE | 0 | $0 | 115,000 | $175,400 | 150,000 | $79,500 |
| 2008 | PURE | 0 | $0 | 64,340 | $332,765 | 165,000 | $87,450 |
| 2007 | PURE | 0 | $0 | 51,186 | $159,966 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-12-01 | PURE | Option Ex | 8,900 | .53 | 4,717 |
| 2010-12-02 | PURE | Option Ex | 1,100 | .53 | 583 |
| 2010-12-01 | PURE | Sale | 8,900 | 2.15 | 19,090 |
| 2010-12-02 | PURE | Sale | 1,100 | 2.17 | 2,388 |
| 2010-11-02 | PURE | Sale | 17,700 | 2.48 | 43,860 |
| 2010-11-03 | PURE | Option Ex | 2,000 | .53 | 1,060 |
| 2010-11-02 | PURE | Option Ex | 17,700 | .53 | 9,381 |
| 2010-11-03 | PURE | Sale | 2,000 | 2.38 | 4,756 |
| 2010-10-28 | PURE | Option Ex | 20,000 | .53 | 10,600 |
| 2010-11-01 | PURE | Option Ex | 10,300 | .53 | 5,459 |
| 2010-10-28 | PURE | Sale | 20,000 | 3.00 | 60,000 |
| 2010-11-01 | PURE | Sale | 10,300 | 2.46 | 25,389 |
| 2010-10-01 | PURE | Option Ex | 17,700 | .53 | 9,381 |
| 2010-10-01 | PURE | Sale | 17,700 | 2.38 | 42,126 |
| 2010-10-05 | PURE | Sale | 4,500 | 2.34 | 10,530 |
| 2010-10-04 | PURE | Sale | 7,800 | 2.30 | 17,940 |
| 2010-10-05 | PURE | Option Ex | 4,500 | .53 | 2,385 |
| 2010-10-04 | PURE | Option Ex | 7,800 | .53 | 4,134 |
| 2010-09-13 | PURE | Option Ex | 12,500 | .53 | 6,625 |
| 2010-09-10 | PURE | Sale | 11,100 | 2.01 | 22,310 |
| 2010-09-09 | PURE | Sale | 6,400 | 2.00 | 12,800 |
| 2010-09-10 | PURE | Option Ex | 11,100 | .53 | 5,883 |
| 2010-09-09 | PURE | Option Ex | 6,400 | .53 | 3,392 |
| 2010-09-13 | PURE | Sale | 12,500 | 2.11 | 26,375 |
| 2010-08-11 | PURE | Option Ex | 25,000 | .53 | 13,250 |
| 2010-08-12 | PURE | Option Ex | 5,000 | .53 | 2,650 |
| 2010-08-11 | PURE | Sale | 25,000 | 2.30 | 57,499 |
| 2010-08-12 | PURE | Sale | 5,000 | 2.27 | 11,350 |
| 2010-07-13 | PURE | Sale | 20,000 | 2.08 | 41,600 |
| 2009-10-27 | PURE | Sale | 5,000 | 2.00 | 10,000 |
| 2009-09-01 | PURE | Sale | 5,000 | 2.08 | 10,400 |
| 2009-08-24 | PURE | Sale | 2,101 | 2.00 | 4,202 |
| 2009-08-11 | PURE | Sale | 599 | 2.00 | 1,198 |
| 2009-08-10 | PURE | Sale | 2,300 | 2.00 | 4,600 |
| 2009-07-21 | PURE | Sale | 100,000 | 1.45 | 145,000 |
| 2009-03-25 | PURE | Option Ex | 150,000 | .53 | 79,500 |
| 2008-10-16 | PURE | Option Ex | 165,000 | .53 | 87,450 |
| 2008-07-28 | PURE | Sale | 6,800 | 5.04 | 34,238 |
| 2008-07-29 | PURE | Sale | 12,200 | 5.01 | 61,122 |
| 2008-07-30 | PURE | Sale | 1,000 | 5.00 | 5,000 |
| 2008-05-07 | PURE | Sale | 12,300 | 5.00 | 61,500 |
| 2008-04-18 | PURE | Sale | 10,000 | 4.75 | 47,500 |
| 2008-02-14 | PURE | Sale | 10,000 | 5.60 | 56,000 |
| 2008-02-15 | PURE | Sale | 5,000 | 5.52 | 27,599 |
| 2008-02-19 | PURE | Sale | 5,000 | 5.55 | 27,750 |
| 2008-01-10 | PURE | Sale | 2,040 | 5.91 | 12,056 |
| 2007-07-26 | PURE | Sale | 20,768 | 3.52 | 73,020 |
| 2007-07-30 | PURE | Sale | 14,878 | 3.40 | 50,600 |
| 2007-03-21 | PURE | Sale | 6,000 | 2.31 | 13,860 |
| 2007-02-27 | PURE | Sale | 3,000 | 2.34 | 7,020 |
| 2007-02-21 | PURE | Sale | 1,500 | 2.32 | 3,479 |
| 2007-02-12 | PURE | Sale | 3,000 | 2.40 | 7,214 |
| 2007-02-05 | PURE | Sale | 2,040 | 2.34 | 4,773 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brovarone Dennis (Director of Pure Bioscience, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.